NCT06652997

SPH3348 Tablets in a Single-center, Randomized, Open-label, Single-dose, Two-period, Two-sequence Crossover Design Food Effect Study in Healthy Chinese Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 16 (actual)
• Sponsor: West China Second University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The goal of this clinical trial is to evaluate the pharmacokinetic (PK) characteristics of single oral doses of SPH3348 tablets in healthy subjects under fasting and fed conditions, as well as the impact of food on PK.

Conditions

• Antitumor Drug
• Pharmacokinetics

Interventions

Type	Name	Description
DRUG	SPH3348	Single oral administration of SPH3348 tablets（480mg） under fasting and fed conditions

Timeline

• Start date: 2022-07-15
• Primary completion: 2022-08-14
• Completion: 2022-11-02
• First posted: 2024-10-22
• Last updated: 2024-10-22

Locations

1 site across 1 country: China